Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04913285
Title A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Kinnate Biopharma
Indications

Advanced Solid Tumor

melanoma

Therapies

Binimetinib + KIN-2787

KIN-2787

Age Groups: senior | adult
Covered Countries USA | ESP

Additional content available in CKB BOOST